Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name APR-246
Trade Name
Synonyms p53 activator APR-246|PRIMA-1MET|PRIMA-1 analogue APR-246|Eprenetapopt
Drug Descriptions

APR-246 is an analogue of PRIMA-1, which modifies the core domain of mutant p53, resulting in restoration of wild-type p53 conformation and reactivation of normal p53 function, leading to increased cell cycle arrest and tumor cell death (PMID: 20498645, PMID: 29670092).

DrugClasses p53 Activator 11
CAS Registry Number 5291-32-7
NCIT ID C85465


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Acalabrutinib + APR-246 APR-246 Acalabrutinib 0 1
APR-246 APR-246 6 0
APR-246 + Azacitidine APR-246 Azacitidine 0 3
APR-246 + Azacitidine + Venetoclax APR-246 Azacitidine Venetoclax 0 1
APR-246 + Carboplatin APR-246 Carboplatin 0 0
APR-246 + Carboplatin + Doxorubicin APR-246 Carboplatin Doxorubicin 0 1
APR-246 + Cisplatin APR-246 Cisplatin 11 0
APR-246 + Ibrutinib APR-246 Ibrutinib 0 0
APR-246 + Ibrutinib + Rituximab + Venetoclax APR-246 Ibrutinib Rituximab Venetoclax 0 0
APR-246 + Pembrolizumab APR-246 Pembrolizumab 0 1
APR-246 + Radiotherapy APR-246 Radiotherapy 0 0
APR-246 + Rituximab + Venetoclax APR-246 Rituximab Venetoclax 0 1
APR-246 + Venetoclax APR-246 Venetoclax 0 1

Additional content available in CKB BOOST